Home / BusinessBusinessCNBCBusinessCNBC·Jun 5, 2026·1 min readAstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of successAstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessJun 5, 2026 · 1 minAstraZeneca Broadens US Growth PushBloombergScienceBloombergScienceJun 17, 2026 · 1 minUniQure Shares Soar After FDA Reversal on Its Huntington’s TherapyBloombergWorldAllAfricaWorldJun 18, 2026 · 1 minAfrica: Tanzania Targets Africa Pharma Manufacturing Hub StatusAllAfricaHealthBloombergHealthJun 16, 2026 · 1 minAI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David RomanBloomberg
ScienceBloombergScienceJun 17, 2026 · 1 minUniQure Shares Soar After FDA Reversal on Its Huntington’s TherapyBloomberg
WorldAllAfricaWorldJun 18, 2026 · 1 minAfrica: Tanzania Targets Africa Pharma Manufacturing Hub StatusAllAfrica
HealthBloombergHealthJun 16, 2026 · 1 minAI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David RomanBloomberg